Bristol Myers Squibb Co (BMY) results explained: sales up 5%

Quantooo Lab · 2026-10-29

What happened?

Bristol Myers Squibb Co (BMY) reported results on 29 Oct, covering the 9 months to 30 Sep.

The numbers in plain words

Sales were up 5.2% compared with the same period a year earlier. The company is funded less by borrowing than a year ago (74% of assets vs 81%).

Source: the company's 10-Q filed 2026-10-29.

How did the share price react?

Since the results, the share price has moved +1.35% (to the close of 29 Oct), while the S&P 500 moved −0.38%.

What changed in our score?

Our score went from 58 to 57 out of 100; the fundamentals part went from 57 to 60. Every step of the calculation: BMY stock page.

How bumpy could the next month be?

Our volatility model expects the next month to be about as usual for BMY (26% a year vs a normal 26%).

What does it mean?

Results describe the past few months. They don't tell you where the price goes next, and our own tests found our scores don't reliably predict that either.

Educational, not investment advice.